RCM
ARIA

Reynolds Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Reynolds Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17,200
Closed -$142K – 218
2015
Q2 		$142K Buy
+17,200
New +$152K 0.14% 202
2013
Q3 		– Sell
-10,300
Closed -$181K – 481
2013
Q2 		$181K Buy
+10,300
New +$183K 0.13% 327

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Reynolds Capital Management's ARIA Position: Q3 2015 in Review

Reynolds Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2015, closing a stake of 17,200 shares — an estimated $142K sold.

Reynolds Capital Management first reported a position in ARIA in Q2 2013 and held it in 2 quarters. The position peaked at $181K in Q2 2013. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

  • Reynolds Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 17,200 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $142K.
  • Reynolds Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Reynolds Capital Management's Ariad Pharmaceuticals Inc position peaked at $181K in Q2 2013.
  • 175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on Reynolds Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.